Cambridge Investment Research Advisors
FBIO icon

Cambridge Investment Research Advisors’s Fortress Biotech FBIO Stock Holding History

Cambridge Investment Research Advisors’s Portfolio FBIO Stock Details FBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,004,365
Closed -$1.57M – 3669
2025
Q1 		$1.57M Buy
1,004,365
+80,058
+9% +$141K 0.01% 1508
2024
Q4 		$1.87M Buy
924,307
+369,907
+67% +$670K 0.01% 1403
2024
Q3 		$801K Buy
554,400
+465,500
+524% +$886K ﹤0.01% 2035
2024
Q2 		$152K Buy
+88,900
New +$161K ﹤0.01% 3100

Other funds holding FBIO

SF
Summit Financial Parsippany, New Jersey $7.85B AUM 20.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KAS
Kestra Advisory Services Austin, Texas $26.4B AUM 21.05% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
PAM
PVG Asset Management Golden, Colorado $173M AUM 64.51% 1-Year Est. Return
SAM
Shikiar Asset Management New York $347M AUM 23.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Cambridge Investment Research Advisors's FBIO Position: Q2 2025 in Review

Cambridge Investment Research Advisors sold out of Fortress Biotech (FBIO) in Q2 2025, closing a stake of 1,004,365 shares — an estimated $1.57M sold.

Cambridge Investment Research Advisors first reported a position in FBIO in Q2 2024 and held it in 4 quarters. The position peaked at $1.87M in Q4 2024. 49 funds tracked by Wall St. Rank hold FBIO as of Q2 2025.

  • Cambridge Investment Research Advisors reported no remaining Fortress Biotech position as of Q2 2025 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 1,004,365 Fortress Biotech shares in Q2 2025, an estimated $1.57M.
  • Cambridge Investment Research Advisors first reported a position in Fortress Biotech in Q2 2024 and held it in 4 quarters.
  • Cambridge Investment Research Advisors's Fortress Biotech position peaked at $1.87M in Q4 2024.
  • 49 funds tracked by Wall St. Rank held Fortress Biotech as of Q2 2025.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2025, filed 31 Jul 2025.